The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)
NCT ID: NCT07058935
Last Updated: 2025-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2025-03-17
2035-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry
NCT07296016
The Asian Pacific TAVR Multicenter Registry
NCT02195102
Portico Valve-in-Valve Retrospective Registry
NCT05002088
Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes
NCT05389631
TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease
NCT05536310
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mitral Valve-in-Valve
Patients who have undergone or will undergo a transcatheter mitral valve-in-valve procedure.
No interventions assigned to this group
Mitral Valve-in-Ring
Patients who have undergone or will undergo a transcatheter mitral valve-in-ring procedure.
No interventions assigned to this group
Tricuspid Valve-in-Valve
Patients who have undergone or will undergo a transcatheter tricuspid valve-in-valve procedure.
No interventions assigned to this group
Tricuspid Valve-in-Ring
Patients who have undergone or will undergo a transcatheter tricuspid valve-in-ring procedure.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Had at least one documented Mitral valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Mitral valve-in-valve/valve-in-ring procedure. (Prospective) OR Had at least one documented Tricuspid valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Tricuspid valve-in-valve/valve-in-ring procedure. (Prospective)
Exclusion Criteria
2. Any other conditions which investigator deems unsuitable for participation.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Edwards Lifesciences
INDUSTRY
National Heart Centre Singapore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
John Hunter Hospital
New Lambton Heights, , Australia
Prince of Wales Hospital
Hong Kong, , Hong Kong
Queen Elizabeth Hospital
Hong Kong, , Hong Kong
MGM Healthcare Pvt Ltd
Chennai, Tamil Nadu, India
The Madras Medical Mission
Chennai, Tamil Nadu, India
Waikato Hospital
Hamilton, , New Zealand
National Heart Centre Singapore
Singapore, , Singapore
Ramathibodi Hospital
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-4264
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.